Walpar Nutritions Limited

₹24.35As of Sun 8 Nov 2026, 12:00 UTC
NSE:WALPARHealthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR 4.25%
Div yield —
ROE 14.48%
Pharmaceutical Preparations
Beta (5Y) (0.60)
PE TTM 9.419
TSR TTM (44.66%)
Mkt cap ₹228.7M
ROIC 10.39%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹29
20.01%
(38.65%)
Hold 8|6|8|0|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.23
0.25
0.28
0.31
(4.07%)
6.79%
19.28%
31.96%
Revenue₹M
20.87
21.59
22.43
23.20
9.48%
7.11%
9.86%
16.44%
Peers (US$2.435M)
Cap (US$)
PE
3.016M
11.78x
2.366M
—
Capital
TTM
5Y
10Y
Leveragex
1.359
0.253
0.261
EBIT/Intx
2.009
2.205
2.034
Own earn%
(333.46)
(29.24)
(44.75)
Sh yield%
18.56
14.02
13.84
Owners
Insiders/Inst%
11.38
27.87
Short interest%
0.73
SBC / revenue%
3.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
20–23
$1 testx
—
Incr. ROIC%
3